Bing Xin

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Immune Response

Top Venues

Hepatology (Baltimore, Md.)

UCSD

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UCSD Aug 15 2017

United States

posdoc :: pathology

Publications

Jacey J Liu, Bing Xin, Li Du, Lydia Chen, Yanyan Long, Gen-Sheng Feng
Pharmaceutical SH2 domain-containing protein tyrosine phosphatase 2 inhibition suppresses primary and metastasized liver tumors by provoking hepatic innate immunity. Hepatology (Baltimore, Md.) (2022)
Bing Xin, Meixiang Yang, Panyisha Wu, Li Du, Xingyu Deng, Enfu Hui, Gen-Sheng Feng
Enhancing the Therapeutic Efficacy of PD-L1 Antibody for Metastasized Liver Cancer by Overcoming Hepatic Immunotolerance. Hepatology (Baltimore, Md.) (2021)
Liang Wen, Bing Xin, Panyisha Wu, Chia-Hao Lin, Chuanhui Peng, Gaowei Wang, Jin Lee, Li-Fan Lu, Gen-Sheng Feng
An Efficient Combination Immunotherapy for Primary Liver Cancer by Harmonized Activation of Innate and Adaptive Immunity in Mice. Hepatology (Baltimore, Md.) 69 (6) (2019)